Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002378187 | SCV002668018 | likely benign | Inborn genetic diseases | 2019-06-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003108052 | SCV003781784 | likely benign | not provided | 2024-04-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004548280 | SCV004116321 | uncertain significance | CHD8-related disorder | 2022-11-23 | criteria provided, single submitter | clinical testing | The CHD8 c.1234G>A variant is predicted to result in the amino acid substitution p.Ala412Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.029% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/14-21896395-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |